We are live on !
Find out more
Prostatis Group Portfolio holdings
AUM
$429M
Turnover
26.7%
1-Year Est. Return
26.55%
This Fund
S&P 500
This Quarter Est. Return
-4.6%
1 Year Est. Return
+26.55%
3 Year Est. Return
+72.92%
5 Year Est. Return
+90.2%
10 Year Est. Return
–
AUM
$86.8M
AUM Growth
+$22.6M
(+35%)
Cap. Flow
+$29.2M
Cap. Flow % of AUM
Cap. Flow %
33.63%
Top 10 Holdings %
Top 10 Hldgs %
53.75%
Holding
75
New
28
Increased
19
Reduced
14
Closed
11
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$7.39M |
| 2 |
Invesco S&P 500 GARP ETF
SPGP
|
+$6.43M |
| 3 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$5.75M |
| 4 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$4.4M |
| 5 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$25.7M |
| 2 |
iShares Core High Dividend ETF
HDV
|
+$5.62M |
| 3 |
Vanguard Information Technology ETF
VGT
|
+$580K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$316K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$311K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.48% |
| 2 | Healthcare | 6.05% |
| 3 | Technology | 5.14% |
| 4 | Consumer Discretionary | 4.26% |
| 5 | Financials | 3.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amplify CWP Enhanced Dividend Income ETF
DIVO
$8.03B
| $9.5M | 10.97% |
297,262
+49,430
| +20% | +$1.71M |
2021 Q1
6 quarters
|
|
|
2
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$192M
| $6.6M | 7.61% |
+206,903
| New | +$7.39M |
2022 Q3
0 quarters
|
|
|
3
Invesco S&P 500 GARP ETF
SPGP
$2.08B
| $5.78M | 6.67% |
+77,306
| New | +$6.43M |
2022 Q3
0 quarters
|
|
|
4
Vanguard Intermediate-Term Bond ETF
BIV
$28.5B
| $5.47M | 6.3% |
+74,381
| New | +$5.75M |
2022 Q3
0 quarters
|
|
|
5
Invesco S&P MidCap Momentum ETF
XMMO
$6.71B
| $4.01M | 4.62% |
+57,437
| New | +$4.4M |
2022 Q3
0 quarters
|
|
6
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $3.72M | 4.29% |
49,732
-1,839
| -4% | -$141K |
2020 Q4
7 quarters
|
|
|
7
FT Vest Fund of Deep Buffer ETFs
BUFD
$2.21B
| $3.52M | 4.06% |
+184,380
| New | +$3.66M |
2022 Q3
0 quarters
|
|
8
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.1B
| $2.79M | 3.22% |
+120,832
| New | +$3.07M |
2022 Q3
0 quarters
|
|
9
First Trust Capital Strength ETF
FTCS
$7.77B
| $2.78M | 3.21% |
+41,913
| New | +$3.01M |
2022 Q3
0 quarters
|
|
10
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $2.45M | 2.82% |
+19,226
| New | +$2.71M |
2022 Q3
0 quarters
|
|
11
Microsoft
MSFT
$3.94T
| $2.31M | 2.66% |
9,905
+4,560
| +85% | +$1.2M |
2019 Q4
11 quarters
|
|
12
Apple
AAPL
$5.06T
| $2.16M | 2.48% |
15,595
+6,738
| +76% | +$1.06M |
2019 Q4
11 quarters
|
|
13
Thermo Fisher Scientific
TMO
$258B
| $2.08M | 2.4% |
4,104
+1,193
| +41% | +$668K |
2019 Q4
11 quarters
|
|
14
iShares TIPS Bond ETF
TIP
$14.6B
| $2.03M | 2.34% |
+19,329
| New | +$2.19M |
2022 Q3
0 quarters
|
|
|
15
First Trust Enhanced Short Maturity ETF
FTSM
$6.74B
| $1.99M | 2.29% |
33,478
-433,163
| -93% | -$25.7M |
2022 Q2
1 quarter
|
|
16
Vanguard Long-Term Bond ETF
BLV
$5.53B
| $1.94M | 2.23% |
+26,916
| New | +$2.13M |
2022 Q3
0 quarters
|
|
17
Vanguard Total International Bond ETF
BNDX
$83.8B
| $1.64M | 1.89% |
+34,342
| New | +$1.71M |
2022 Q3
0 quarters
|
|
18
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.57M | 1.81% |
+22,034
| New | +$1.67M |
2022 Q3
0 quarters
|
|
19
Amazon
AMZN
$2.74T
| $1.55M | 1.79% |
13,726
+8,189
| +148% | +$1.04M |
2020 Q2
9 quarters
|
|
20
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.6B
| $1.48M | 1.7% |
+38,512
| New | +$1.57M |
2022 Q3
0 quarters
|
|
21
Amgen
AMGN
$241B
| $1.31M | 1.51% |
5,800
+4,596
| +382% | +$1.11M |
2019 Q4
11 quarters
|
|
22
Tesla
TSLA
$1.61T
| $1.24M | 1.42% |
+4,660
| New | +$1.3M |
2022 Q3
0 quarters
|
|
23
SPDR Gold Trust
GLD
$136B
| $1.05M | 1.21% |
+6,783
| New | +$1.09M |
2022 Q3
0 quarters
|
|
24
Berkshire Hathaway Class B
BRK.B
$1.16T
| $1.01M | 1.16% |
+3,764
| New | +$1.07M |
2022 Q3
0 quarters
|
|
25
iShares Core S&P 500 ETF
IVV
$885B
| $1M | 1.16% |
+2,801
| New | +$1.12M |
2022 Q3
0 quarters
|
|
Similar funds
PA
Prostatis Group's Q3 2022 Portfolio in Review
As of Q3 2022, Prostatis Group held 75 positions worth $86.8M, up 35% from $64.2M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Prostatis Group deployed $29.2M of net new capital in Q3 2022, opening 28 new positions and adding to 19 existing holdings. Its largest new stake was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $25.7M trimmed.
- Prostatis Group's largest Q3 2022 buy was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.
- Prostatis Group added most to Amplify CWP Enhanced Dividend Income ETF in Q3 2022, an estimated $1.71M increase.
- Prostatis Group's biggest Q3 2022 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $25.7M.
- Prostatis Group fully exited iShares Core High Dividend ETF in Q3 2022, selling an estimated $5.62M.
- Prostatis Group's ten largest holdings make up 54% of its $86.8M portfolio in Q3 2022.
- Prostatis Group opened 28 new positions and closed 11 in Q3 2022.
- Prostatis Group's portfolio value rose 35% quarter-over-quarter to $86.8M.
Based on Prostatis Group's 13F filing for Q3 2022, filed 23 Mar 2023.